NO20012834L - Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus - Google Patents

Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus

Info

Publication number
NO20012834L
NO20012834L NO20012834A NO20012834A NO20012834L NO 20012834 L NO20012834 L NO 20012834L NO 20012834 A NO20012834 A NO 20012834A NO 20012834 A NO20012834 A NO 20012834A NO 20012834 L NO20012834 L NO 20012834L
Authority
NO
Norway
Prior art keywords
carbon atoms
alkyl
perhaloalkyl
aryl
hydrogen
Prior art date
Application number
NO20012834A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012834D0 (no
Inventor
Jonathan David Bloom
Martin Joseph Digrandi
Russel George Dushin
Stanley Albert Lang
Bryan Mark O'hara
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO20012834D0 publication Critical patent/NO20012834D0/no
Publication of NO20012834L publication Critical patent/NO20012834L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/22Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
NO20012834A 1998-12-09 2001-06-08 Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus NO20012834L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20831698A 1998-12-09 1998-12-09
PCT/US1999/028844 WO2000034237A2 (en) 1998-12-09 1999-12-06 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses

Publications (2)

Publication Number Publication Date
NO20012834D0 NO20012834D0 (no) 2001-06-08
NO20012834L true NO20012834L (no) 2001-08-07

Family

ID=22774137

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012834A NO20012834L (no) 1998-12-09 2001-06-08 Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus

Country Status (15)

Country Link
EP (1) EP1137633A2 (cs)
JP (1) JP2002531544A (cs)
KR (1) KR20010087413A (cs)
CN (1) CN1333750A (cs)
AU (1) AU3111200A (cs)
BR (1) BR9916041A (cs)
CA (1) CA2350899A1 (cs)
CZ (1) CZ20012060A3 (cs)
EA (1) EA200100640A1 (cs)
HU (1) HUP0104944A3 (cs)
IL (1) IL143204A0 (cs)
NO (1) NO20012834L (cs)
PL (1) PL349131A1 (cs)
WO (1) WO2000034237A2 (cs)
ZA (1) ZA200104142B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166028A (en) * 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
ATE311366T1 (de) 2000-02-29 2005-12-15 Millennium Pharm Inc Benzamide und ähnliche inhibitoren vom faktor xa
CA2503445C (en) * 2002-10-24 2012-07-31 Merck Patent Gesellschaft Mit Beschraenkter Haftung Methylene urea derivatives as raf-kinase inhibitors
US7220768B2 (en) * 2003-02-11 2007-05-22 Wyeth Holdings Corp. Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
EP1660661A2 (en) 2003-08-08 2006-05-31 Arriva Pharmaceuticals, Inc. Methods of protein production in yeast
KR100891599B1 (ko) 2003-08-29 2009-04-08 미쓰이 가가쿠 가부시키가이샤 농업용 또는 원예용 살충제 및 그의 이용 방법
EP1737499A4 (en) 2004-03-09 2009-07-22 Arriva Pharmaceuticals Inc TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE BY INHALATION OF LOW DOSES OF A PROTEASE HEMMER
WO2008043840A2 (en) * 2006-10-13 2008-04-17 Lica Pharmaceuticals Anti-infective thiourea compounds
PT2077995E (pt) 2006-11-02 2012-05-10 Millennium Pharm Inc Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa
CN108619123A (zh) * 2018-03-13 2018-10-09 武汉威立得生物医药有限公司 Tenovin-1在制备防治人类疱疹病毒感染药物中的应用
WO2019193541A1 (en) * 2018-04-06 2019-10-10 Glaxosmithkline Intellectual Property Development Limited Bicyclic aromatic ring derivatives of formula (i) as atf4 inhibitors
CN112807294B (zh) * 2019-11-18 2023-09-05 武汉大学 一种酰基硫脲类化合物在制备治疗或预防单纯疱疹病毒i型感染药物中的应用
WO2022150962A1 (en) * 2021-01-12 2022-07-21 Westlake Pharmaceutical (Hangzhou) Co., Ltd. Protease inhibitors, preparation, and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE298741T1 (de) * 1997-04-10 2005-07-15 Pharmacia & Upjohn Co Llc Polyaromatische verbindungen zur behandlung von herpes-infektionen

Also Published As

Publication number Publication date
WO2000034237A3 (en) 2000-11-23
HUP0104944A3 (en) 2003-03-28
CA2350899A1 (en) 2000-06-15
BR9916041A (pt) 2001-12-04
AU3111200A (en) 2000-06-26
JP2002531544A (ja) 2002-09-24
PL349131A1 (en) 2002-07-01
CN1333750A (zh) 2002-01-30
EP1137633A2 (en) 2001-10-04
CZ20012060A3 (cs) 2001-11-14
HUP0104944A2 (hu) 2002-04-29
EA200100640A1 (ru) 2001-12-24
NO20012834D0 (no) 2001-06-08
WO2000034237A2 (en) 2000-06-15
ZA200104142B (en) 2002-10-25
IL143204A0 (en) 2002-04-21
KR20010087413A (ko) 2001-09-15

Similar Documents

Publication Publication Date Title
NO20012834L (no) Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus
EA200000993A1 (ru) Тризамещенные производные 1,3,5-триазина для лечения вич-инфекционных заболеваний
ATE11535T1 (de) N-heteroaryl-alkylendiamine, verfahren zu ihrer herstellung sowie ihre verwendung.
HK1049662A1 (zh) 細胞周期蛋白依賴激酶氨基噻唑抑制劑
WO2000034258A3 (en) Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
CA2301543A1 (en) Azetidinone derivatives for the treatment of hcmv infections
DE69108299D1 (de) Antiherpes-Peptidderivate mit einem 1,4-Dioxo-C4-N-Terminus.
UA50725C2 (uk) Похідні 2-[(2-алкокси-6-трифторметилпіримідин-4-іл)оксиметилен]- фенілоцтової кислоти, спосіб їх отримання, застосування піримідин-4-олів для отримання цих похідних та засіб для боротьби зі шкідниками
WO2000034261A3 (en) Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
BG105583A (en) Thiourea as inhibitor of herpes viruses
NO20012837L (no) Tiourea-inhibitorer for herpesvirus
NO177932C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive indenoindolforbindelser
WO2000034260A3 (en) Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
DK568088D0 (da) 3,5-dihydroxy-6,8-nonadiensyre-forbindelser og farmaceutiske praeparater indeholdende disse samt 5-hydroxy-3-oxo-6,8-nonadiensyreester-forbindelser til anvendelse som udgangsmateriale ved deres fremstilling
NO900697L (no) Fremgangsmaate for fremstilling av terapeutisk aktive acetamid-derivater.
BR9916042A (pt) Composto, composição farmacêutica, e, processospara inibir a replicação de um vìrus herpes, e detratamento de um paciente que sofra de umainfecção do vìrus herpes
CA2301967A1 (en) Azetidinone derivatives for the treatment of hcmv infections
NO940019L (no) Fremgangsmåte for fremstilling av svovelholdige imidazolderivater
DK0570245T3 (da) Octahydronaphthalenoximderivater til inbibering af kolesterolbiosyntese, deres fremstilling og anvendelse
ATE94878T1 (de) Imidazobenzodiazepine und ihre saeureadditionssalze, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
DE69014337D1 (de) Verwendung von 5-Alkylpyridazin-Derivaten als Medikamente zur Beeinflussung des cholinergen Systems.
ATE168995T1 (de) N-(mercaptoacyl)aminosäure, ihre herstellung, ihre therapeutische verwendung und sie enthaltende pharmazeutische zusammensetzungen
KR900003165A (ko) 2-아미노-4-모르폴리노-6-프로필-1,3,5-트리아진
RU2032674C1 (ru) Вещество, обладающее противогерпесным действием
WO2008051244A3 (en) Anthranilic acid derivatives useful in treating infection with hepatitis c virus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application